Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Daniel C. Butler, Eric Simpson, Emma Guttman-Yassky, Lawrence F. Eichenfield, Alexandra K. Golant, John Y. M. Koo, April W. Armstrong, Andrew F. Alexis, Peter A. Lio, Justin W. Marson & Mark Lebwohl. (2022) The atopic dermatitis spectrum disorder. Recognizing the clinical heterogeneity in patients with atopic related skin conditions in order to improve therapeutic decision-making and outcomes: an expert panel consensus statement. Journal of Dermatological Treatment 33:4, pages 2397-2399.
Read now
Read now
Sonja Senner, Marlene Seegräber, Surina Frey, Benjamin Kendziora, Laurie Eicher & Andreas Wollenberg. (2020) Dupilumab for the treatment of adolescents with atopic dermatitis. Expert Review of Clinical Immunology 16:7, pages 641-650.
Read now
Read now
Articles from other publishers (36)
Spencer I. Danto, Nikolaos Tsamandouras, Padmalatha Reddy, Steven Gilbert, Jessica Mancuso, Karen Page, Elena Peeva, Michael S. Vincent & Jean S. Beebe. (2023) Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PF‐06817024 in Healthy Participants, Participants with Chronic Rhinosinusitis with Nasal Polyps, and Participants with Atopic Dermatitis: A Phase 1, Randomized, Double‐Blind, Placebo‐Controlled Study. The Journal of Clinical Pharmacology.
Crossref
Crossref
Larissa StarlingSérgio Duarte Dortas JuniorOmar LupiSolange Valle. (2023) Atopic dermatitis in teenagers and adults: Clinical features of a tertiary referral hospital. Indian Journal of Skin Allergy 2, pages 81-85.
Crossref
Crossref
Martina Maurelli, Paolo Gisondi, Francesco Bellinato, Alessandro Mantovani, Giovanni Targher & Giampiero Girolomoni. (2023) Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis. Journal of Clinical Medicine 12:18, pages 6057.
Crossref
Crossref
Sayali Prakash Pradhan, Salman Naveed Sadiq, Cristian Cartes, Parastoo Babakinejad, Stephanie Ball, Nick J Reynolds, Simon Meggitt & Francisco C Figueiredo. (2023) Dupilumab induced ocular surface disease: A prospective case series. European Journal of Ophthalmology.
Crossref
Crossref
Gilli Lewis & Debbie Rickard. 2023. Care Planning in Children and Young People's Nursing 2e. Care Planning in Children and Young People's Nursing 2e
281
291
.
Avril Collinson, Lisa Waddell, Amy Freeman‐Hughes & Mary Hickson. (2023) Impact of a dietitian in general practice: paediatric food allergy. Journal of Human Nutrition and Dietetics 36:3, pages 707-715.
Crossref
Crossref
Hanene Bzioueche, Myriam Tamelghaghet, Bérengère Chignon-Sicard, Noémie Bazile, Pauline Hauchecorne, Maria Barbero Calderón, Pauline Meunier, Stéphane Rocchi, Thierry Passeron & Meri K. Tulic. (2023) Ceramide AD™ Restores Skin Integrity and Function following Exposure to House Dust Mite. International Journal of Molecular Sciences 24:11, pages 9234.
Crossref
Crossref
Xiaohu Li, Lijin Liang, Sheng Li, Chunyang Wang, Alberto Cucco, Xiaohang Du, Jie Zhang, Shang Wang & Weiling Yuan. (2023) Effect of acupuncture in eczema: An overview of systematic reviews. Complementary Therapies in Medicine 73, pages 102925.
Crossref
Crossref
Alfred Ammoury, Ahmed Ameen, Mahira Hamdy El Sayed, Sultan Al-Khenaizan, Nehal Hassan & Marcelle Ghoubar. (2023) Patterns of Clinical Management of Atopic Dermatitis: A Survey of Three Physician Specialties in the Middle East. Dermatology and Therapy 13:3, pages 769-785.
Crossref
Crossref
Martyna Scibiorek, Nontobeko Mthembu, Sandisiwe Mangali, Amkele Ngomti, Paul Ikwegbue, Frank Brombacher & Sabelo Hadebe. (2023) IL-4Rα signalling in B cells and T cells play differential roles in acute and chronic atopic dermatitis. Scientific Reports 13:1.
Crossref
Crossref
Megan N. Landis, Mark Arya, Stacy Smith, Zoe Draelos, Lisa Usdan, Sanela Tarabar, Vivek Pradhan, Sudeepta Aggarwal, Christopher Banfield, Elena Peeva, Michael S. Vincent, Vanja Sikirica, Jason Xenakis & Jean S. Beebe. (2022) Efficacy and safety of topical brepocitinib for the treatment of mild-to-moderate atopic dermatitis: a phase IIb, randomized, double-blind, vehicle-controlled, dose-ranging and parallel-group study. British Journal of Dermatology 187:6, pages 878-887.
Crossref
Crossref
Sang-Won Kim & Jung-Hyun Kim. (2022) Establishing an experimental model for canine atopic dermatitis through epicutaneous application of Dermatophagoides farinae. Frontiers in Veterinary Science 9.
Crossref
Crossref
Michael W Mather, Hassan Mohammed & Janet A Wilson. (2022) Improving patient care pathways in otitis externa. Family Practice 39:5, pages 971-973.
Crossref
Crossref
C. Elise Kleyn, Sébastien Barbarot, Catherine Reed, Serena Losi, Lill-Brith von Arx, Camille Robert, Peter Anderson, Susanne Grond & Antonio Costanzo. (2022) Burden of Moderate to Severe Atopic Dermatitis in Adults from France, Italy, and the UK: Patient-Reported Outcomes and Treatment Patterns. Dermatology and Therapy 12:8, pages 1947-1965.
Crossref
Crossref
Georgia G. Rowley, Stephanie J. MacNeill & Matthew J. Ridd. (2022) Emollient satisfaction questionnaire: validation study in children with eczema. Clinical and Experimental Dermatology 47:7, pages 1337-1345.
Crossref
Crossref
Dian-Dong Hou, Ya-Jing Gu, De-Cheng Wang, Yuan Niu, Zi-Ran Xu, Zhuo-Qun Jin, Xin-Xin Wang & Si-Jia Li. (2022) Therapeutic effects of myricetin on atopic dermatitis in vivo and in vitro. Phytomedicine 102, pages 154200.
Crossref
Crossref
Lawrence F. Eichenfield, Stephen Stripling, Selwyn Fung, Amy Cha, Andryann O’Brien & Lawrence A. Schachner. (2022) Recent Developments and Advances in Atopic Dermatitis: A Focus on Epidemiology, Pathophysiology, and Treatment in the Pediatric Setting. Pediatric Drugs 24:4, pages 293-305.
Crossref
Crossref
Hideyuki Ujiie, David Rosmarin, Michael P. Schön, Sonja Ständer, Katharina Boch, Martin Metz, Marcus Maurer, Diamant Thaci, Enno Schmidt, Connor Cole, Kyle T. Amber, Dario Didona, Michael Hertl, Andreas Recke, Hanna Graßhoff, Alexander Hackel, Anja Schumann, Gabriela Riemekasten, Katja Bieber, Gant Sprow, Joshua Dan, Detlef Zillikens, Tanya Sezin, Angela M. Christiano, Kerstin Wolk, Robert Sabat, Khalaf Kridin, Victoria P. Werth & Ralf J. Ludwig. (2022) Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases. Frontiers in Medicine 9.
Crossref
Crossref
Simon Wan Yau Ming, Yi Zhou, Mike Smith & Jay Were. (2022) A Retrospective Database Cohort Study Evaluating the Association Between Immune Suppressive Therapy and the Development of Cancer in Patients with Atopic Dermatitis Within UK Primary Care. European Medical Journal.
Crossref
Crossref
Laura Maintz, Thomas Bieber, Helen D. Simpson & Anne-Laure Demessant-Flavigny. (2022) From Skin Barrier Dysfunction to Systemic Impact of Atopic Dermatitis: Implications for a Precision Approach in Dermocosmetics and Medicine. Journal of Personalized Medicine 12:6, pages 893.
Crossref
Crossref
Eric L. Simpson, Kim A. Papp, Andrew Blauvelt, Chia-Yu Chu, H. Chih-ho Hong, Norito Katoh, Brian M. Calimlim, Jacob P. Thyssen, Albert S. Chiou, Robert Bissonnette, Linda F. Stein Gold, Colleen Wegzyn, Xiaofei Hu, Meng Liu, John Liu, Allan R. Tenorio, Alvina D. Chu & Emma Guttman-Yassky. (2022) Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis. JAMA Dermatology 158:4, pages 404.
Crossref
Crossref
Katy Sorensen, Rosan Meyer, Kate E. Grimshaw, Abbie L. Cawood, Dionisio Acosta‐Mena & Rebecca J. Stratton. (2021) The clinical burden of cow's milk allergy in early childhood: A retrospective cohort study. Immunity, Inflammation and Disease 10:3.
Crossref
Crossref
Joanna Sieniawska, Aleksandra Lesiak, Karol Ciążyński, Joanna Narbutt & Magdalena Ciążyńska. (2022) Impact of the COVID-19 Pandemic on Atopic Dermatitis Patients. International Journal of Environmental Research and Public Health 19:3, pages 1734.
Crossref
Crossref
Nandini Banerjee. (2022)
How effective are interventions to reduce
Staphylococcus aureus
in eczema?
. Clinical & Experimental Allergy 52:2, pages 219-221.
Crossref
Crossref
Manahel Alsabbagh & Amina Ismaeel. (2022) The role of cytokines in atopic dermatitis: a breakthrough in immunopathogenesis and treatment. Acta Dermatovenerologica Alpina Pannonica et Adriatica 31:1.
Crossref
Crossref
Claudia Hülpüsch, Andreas B. Weins, Claudia Traidl‐Hoffmann & Matthias Reiger. (2021) A new era of atopic eczema research: Advances and highlights. Allergy 76:11, pages 3408-3421.
Crossref
Crossref
Heather Newton. (2021) Using emollients to promote safe and effective skin care for patients. Nursing Standard 36:10, pages 77-82.
Crossref
Crossref
Hazrina Ab Hadi, Aine Inani Tarmizi, Kamarul Ariffin Khalid, Márió Gajdács, Adeel Aslam & Shazia Jamshed. (2021) The Epidemiology and Global Burden of Atopic Dermatitis: A Narrative Review. Life 11:9, pages 936.
Crossref
Crossref
Nandini Banerjee & Anjum Grewal. (2021) What is the most effective systemic treatment for atopic dermatitis?. Clinical & Experimental Allergy 51:9, pages 1103-1106.
Crossref
Crossref
Emma Guttman-Yassky, Henrique D Teixeira, Eric L Simpson, Kim A Papp, Aileen L Pangan, Andrew Blauvelt, Diamant Thaçi, Chia-Yu Chu, H Chih-ho Hong, Norito Katoh, Amy S Paller, Brian Calimlim, Yihua Gu, Xiaofei Hu, Meng Liu, Yang Yang, John Liu, Allan R Tenorio, Alvina D Chu & Alan D Irvine. (2021) Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials. The Lancet 397:10290, pages 2151-2168.
Crossref
Crossref
Farah Toron, Maureen P. Neary, Timothy W. Smith, David Gruben, William Romero, Amy Cha, Keyur Patel, Simona Z. Vasileva & Mahreen Ameen. (2021) Clinical and Economic Burden of Mild-to-Moderate Atopic Dermatitis in the UK: A Propensity-Score-Matched Case–Control Study. Dermatology and Therapy 11:3, pages 907-928.
Crossref
Crossref
Ioana Agache, Cezmi A. Akdis, Mubeccel Akdis, Knut Brockow, Tomas Chivato, Stefano del Giacco, Thomas Eiwegger, Kilian Eyerich, Ana Giménez‐Arnau, Jan Gutermuth, Emma Guttman‐Yassky, Marcus Maurer, Graham Ogg, Peck Y. Ong, Liam O’Mahony, Jürgen Schwarze, Amena Warner, Thomas Werfel, Oscar Palomares & Marek Jutel. (2020) EAACI Biologicals Guidelines—dupilumab for children and adults with moderate‐to‐severe atopic dermatitis. Allergy 76:4, pages 988-1009.
Crossref
Crossref
Hyder O Mirghani, Khalid Alhazmi, Salah Alghamdi & Mohammed Alraddadi. (2021) The Cross-Talk Between Atopic Dermatitis and Diabetes Mellitus: A Meta-Analysis. Cureus.
Crossref
Crossref
Marco Manfredini, Serena Liberati, Silvana Ciardo, Laura Bonzano, Mario Guanti, Johanna Chester, Shaniko Kaleci & Giovanni Pellacani. (2020) Microscopic and functional changes observed with dynamic optical coherence tomography for severe refractory atopic dermatitis treated with dupilumab. Skin Research and Technology 26:6, pages 779-787.
Crossref
Crossref
M. Ferrillo, C. Patruno, A. Villani, M. Scalvenzi, G. Fabbrocini, M. D’Andrea & M. Napolitano. (2020) Dermoscopic assessment of long‐term systemic therapy with dupilumab in adult atopic dermatitis. Journal of the European Academy of Dermatology and Venereology 34:11.
Crossref
Crossref
Nicola A. Gray, Pieter J. Naude, Tonya M. Esterhuizen, Nonhlanhla P. Khumalo & Daniel J. Stein. (2020) Interleukin-4 and anxiety in adults with atopic dermatitis. Acta Neuropsychiatrica 32:5, pages 271-273.
Crossref
Crossref